These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 6876452
21. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy. Hausdorff J, Davis E, Long G, Hoppe R, van der Pas M, Lassman C, Kamel O, Jacobs C. Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155 [Abstract] [Full Text] [Related]
22. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma]. Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ. Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686 [Abstract] [Full Text] [Related]
24. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Akpek EK, Ahmed I, Hochberg FH, Soheilian M, Dryja TP, Jakobiec FA, Foster CS. Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554 [Abstract] [Full Text] [Related]
25. Stage IE non-Hodgkin's lymphoma involving the dura: A clinicopathologic study of five cases. Miranda RN, Glantz LK, Myint MA, Levy N, Jackson CL, Rhodes CH, Glantz MJ, Medeiros LJ. Arch Pathol Lab Med; 1996 Mar; 120(3):254-60. PubMed ID: 8629900 [Abstract] [Full Text] [Related]
26. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Pöttgen C, Stuschke M, Stüben G, Schmitz A, Schwechheimer K, Wacker HH, Rauhut F, Kleuker S, Wilhelm H, Grehl S, Fehlings T. Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129 [Abstract] [Full Text] [Related]
32. Cytology of the cerebrospinal fluid in primary malignant lymphomas of the central nervous system. Schmitt-Gräff A, Pfitzer P. Acta Cytol; 1983 Sep; 27(3):267-72. PubMed ID: 6575541 [Abstract] [Full Text] [Related]
34. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated? Johnson GJ, Oken MM, Anderson JR, O'Connell MJ, Glick JH. Lancet; 1984 Sep 22; 2(8404):685-7. PubMed ID: 6147703 [Abstract] [Full Text] [Related]
35. [Neurologic complications in malignant lymphoma]. Nedelcheva E, Popova L, Khadzhiev E. Vutr Boles; 1988 Sep 22; 27(4):58-61. PubMed ID: 3213024 [Abstract] [Full Text] [Related]
36. Effectiveness of chemotherapy for non-Hodgkin's lymphomas. Bloomfield CD, Theologides A, Kennedy BJ. Geriatrics; 1975 Oct 22; 30(10):105-9. PubMed ID: 1158108 [No Abstract] [Full Text] [Related]
37. Treatment of the non-Hodgkin's lymphomas. Canellos GP. Med Times; 1978 Mar 22; 106(3):37-41. PubMed ID: 345038 [No Abstract] [Full Text] [Related]
38. [Curability of advanced malignant lymphoma under conditions of modern combination chemotherapy]. Viollier AF, Senn HJ, Obrecht JP. Schweiz Med Wochenschr; 1978 Dec 09; 108(49):1958-61. PubMed ID: 749192 [Abstract] [Full Text] [Related]
39. Primary central nervous system lymphoma. Hochberg FH, Miller DC. J Neurosurg; 1988 Jun 09; 68(6):835-53. PubMed ID: 3286832 [Abstract] [Full Text] [Related]